Compounds > tripelennamine
Page last updated: 2024-11-05

tripelennamine and Autosomal Dominant Juvenile Parkinson Disease

tripelennamine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies

Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LEHOCZKY, T1

Other Studies

1 other study available for tripelennamine and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
[Synthetic drugs in the therapy of parkinsonism].
    Orvosi hetilap, 1951, Jul-15, Volume: 92, Issue:28

    Topics: Humans; Parkinsonian Disorders; Tripelennamine

1951